Testicular diseases and treatments
Testicular diseases and treatments is a research topic within Surgery. Science Explorer counts 25k research works in it since 1950. 10.2% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on testicular germ cell tumors, covering topics such as diagnosis, treatment, long-term survival, chemotherapy, risk factors, and genetic aspects. It also explores complications, including cardiovascular disease, associated with the treatment of testicular cancer.
- Testicular Cancer
- Germ Cell Tumors
- Survivors
- Chemotherapy
- Diagnosis
- Treatment
- Risk Factors
- Cryptorchidism
- Long-Term Complications
- Genetic Factors
- Research works
- 25k fractional, since 1950
- In the world top 10%
- 2.5k per year above
- Top-10% rate
- 10.2% share of its works in the world top 10%
- Growth, 2018-21 → 2022-25
- +3% the tick is no change
- Largest producer
United States
27% of the 10 largest, 2022-now
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Testicular diseases and treatments research?
By volume, the United States and China publish the most (666 and 489 works in 2022-now).
By volume, 2022-now
- 1
United States 666 works
- 2
China 489 works
- 3
India 341 works
- 4
Japan 186 works
- 5
Türkiye 175 works
- 6
Germany 158 works
- 7
United Kingdom 140 works
- 8
Italy 133 works
- 9
Brazil 89 works
- 10
France 84 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Testicular diseases and treatments research?
By volume in 2022-now, All India Institute of Medical Sciences publishes the most Testicular diseases and treatments research, followed by Indiana University and Harvard University.
By volume, 2022-now
- 1
All India Institute of Medical Sciences
India 34 works
- 2
Indiana University
United States 34 works
- 3
Harvard University
United States 24 works
- 4
Sichuan University
China 21 works
- 5
Sağlık Bilimleri Üniversitesi
Türkiye 18 works
- 6
Sun Yat-sen University
China 18 works
- 7
Mayo Clinic
United States 17 works
- 8
Zhejiang University
China 16 works
- 9
University of Toronto
Canada 15 works
- 10
University of Southern California
United States 15 works
Who are the leading researchers in Testicular diseases and treatments?
The most-cited researchers publishing on Testicular diseases and treatments include Ahmedin Jemal, Freddie Bray and Elaine R. Mardis.
- 1
Ahmedin Jemal
United States 761k citations
- 2
Freddie Bray
France 550k citations
- 3
Elaine R. Mardis
United States 346k citations
- 4
Hermann Brenner
Germany 343k citations
- 5
Richard A. Gibbs
United States 292k citations
- 6
Gordon Brent Mills
United States 265k citations
- 7
Jean‐Louis Vincent
Belgium 262k citations
- 8
Carlo La Vecchia
Italy 258k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Testicular diseases and treatments research done?
The largest centres of Testicular diseases and treatments research in 2022-now are Beijing (China), London (United Kingdom), Istanbul (Türkiye) and New Delhi (India). Among places with at least 20 works in it, it is an unusually large share of all research in Indianapolis.
Largest cities, 2022-now
Where it is the local speciality
- IndianapolisUS · 28.4 works12×
Location quotient: how much more of its research is in Testicular diseases and treatments than the world average.
Where is the best place to study Testicular diseases and treatments?
Among universities, judged by research, Indiana University, Harvard University and University of Copenhagen score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.
Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.
Every institution in Testicular diseases and treatments, country by countryIs Testicular diseases and treatments research growing?
Output in 2022-2025 was 3% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Testicular diseases and treatments.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Testicular diseases and treatments as a percentage of every work published that year, 0.016% in 2024.
Fractional works of Testicular diseases and treatments over all fractional works that year. How the balance of science has shifted.
How much of it reaches the world top 10%
Year by year.
Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.
Discussion
Ask a question or share a note about Testicular diseases and treatments. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.